Trials / Completed
CompletedNCT02653703
L-menthol as a Topical Counter-irritant to TRPA1-induced Neurogenic Inflammation and Pain
High-concentration L-menthol as a Counter-irritant to TRPA1-induced Neurogenic Inflammation, Thermal and Mechanical Hyperalgesia Caused by Trans-cinnamaldehyde
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Aalborg University · Academic / Other
- Sex
- —
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to quantitatively characterize the effects of L-menthol as a topical counter-irritant on cutaneous pain and hyperalgesia provoked by topical application of the TRPA1-agonist trans-cinnamaldehyde (CA) in healthy human volunteers.
Detailed description
This study is designed as an experimental model in healthy humans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Topical L-menthol 40% | Naturally occurring local anaesthetic, counterirritant and TPRM8-agonist. CAS Number: 2216-51-5 |
| OTHER | Vehicle, topical ethanol 96% | Organic solvent CAS Number: 64-17-5 |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2016-01-12
- Last updated
- 2016-01-12
Source: ClinicalTrials.gov record NCT02653703. Inclusion in this directory is not an endorsement.